Clinical trials
Phase 1/2 Uveitis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 4 |
| 2013 | 1 |
| 2014 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Terminated | 4 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Eye Institute (NEI) | 3 |
| Aciont Inc | 1 |
| Clearside Biomedical, Inc. | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 1 |
| National Institutes of Health Clinical Center (CC) | 1 |
| Oregon Health and Science University | 1 |
| Regeneron Pharmaceuticals | 1 |
| University of California, San Francisco | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uveitis | 11 |
| Macular Edema | 4 |
| Panuveitis | 2 |
| Uveitis, Anterior | 2 |
| Uveitis, Intermediate | 2 |
| Uveitis, Posterior | 2 |
| Behcet Syndrome | 1 |
| Choroidal Effusions | 1 |
| Giant Cell Arteritis | 1 |
| Immune System Diseases | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.